Yield10 Bioscience, Inc.
YTEN · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $720 | $4,765 | $2,865 | $2,936 |
| - Cash | $733 | $1,597 | $1,068 | $2,817 |
| + Debt | $2,788 | $3,027 | $3,178 | $3,325 |
| Enterprise Value | $2,775 | $6,195 | $4,975 | $3,444 |
| Revenue | $450 | $300 | $60 | $0 |
| % Growth | 50% | 400% | – | – |
| Gross Profit | $450 | $300 | -$13 | -$72 |
| % Margin | 100% | 100% | -21.7% | – |
| EBITDA | -$3,143 | -$2,374 | -$3,174 | -$3,631 |
| % Margin | -698.4% | -791.3% | -5,290% | – |
| Net Income | -$3,238 | -$2,472 | -$3,266 | -$3,726 |
| % Margin | -719.6% | -824% | -5,443.3% | – |
| EPS Diluted | -5.04 | -4.77 | -6.54 | -9.95 |
| % Growth | -5.7% | 27.1% | 34.3% | – |
| Operating Cash Flow | -$574 | -$903 | -$1,711 | -$2,611 |
| Capital Expenditures | $0 | $0 | -$20 | $1 |
| Free Cash Flow | -$574 | -$903 | -$1,731 | -$2,610 |